MISSION Therapeutics missiontherapeutics.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1132)

MISSION Therapeutics is a private drug discovery company focused on elucidating and targeting the ubiquitin pathway to treat cancers and other diseases. The company is developing small molecule drugs that target deubiquitylating enzymes (DUBs) involved in the DNA damage response, with the aim of inducing synthetic lethality, a powerful mechanism to selectively kill specific tumour cells. Its novel DUB technology platform integrates unique biology, screening and chemistry capabilities to rapidly ...Show all

MISSION Therapeutics is a private drug discovery company focused on elucidating and targeting the ubiquitin pathway to treat cancers and other diseases. The company is developing small molecule drugs that target deubiquitylating enzymes (DUBs) involv...Show all

Company (Alive / Active)

Phone: +44 (0)1223 497 454

Fax:

Babraham Research Campus
Moneta (Building 280)
Cambridge, CB22 3AT
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MISSION Therapeutics $130.9M Apr 11, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MISSION Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compounds Sep 22, 2015 Mar 27, 2018 Patent
Gene encoding labyrinthin, a marker for cancer Oct 23, 2009 Apr 24, 2012 Patent
1-cyano-pyrrolidine compounds as usp30 inhibitors Mar 24, 2016 Application
Methodologies for measuring isopeptidase activity in biological samples in a high throughput manner Jun 15, 2015 Application